The Food and Drug Administration recently announced approval of the RadioGenix™ System, a technetium 99m (Tc-99m) generator. The RadioGenix™ System is developed by NorthStar Medical Radioisotopes, LLC ...
OTTAWA, Ontario--(BUSINESS WIRE)--Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear Generating Station, thanks to the installation ...
− Concentrated molybdenum-98 (cMo-98) enables up to four-fold increase of critical medical radioisotope Mo-99 production in U.S. – BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, ...
LYNCHBURG, Va.--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully labeled technetium-99m (Tc-99m) derived from its proprietary molybdenum-99 (Mo-99) ...
SILVER SPRING, Md., Feb. 8, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration and the Nuclear Regulatory Commission (NRC) today took steps to ensure a stable and secure supply of a ...
Beloit, Wisconsin-based NorthStar Medical Technologies, a provider of radioisotopes used for medical imaging and therapy, has raised $100 million in funding. The investor was Oberland Capital. BELOIT, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results